In addition, the association between the HCV nonstructural protein NS5A and both lipid droplets and apoA1 suggests that both NS5A and the core protein may play roles in the pathogenesis of aberrant lipid metabolism and contribute to liver steatosis, both commonly observed in patients with HCV infection26. This evidence concerns the gene APOA1 and fatty liver disease.